Companies / Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
Nasdaq: ARTVCIK 1817241SAN DIEGO, CA
Financials · FY2025
Ownership
48.9M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 39.94% | 19,528,602 |
| Institutions | 15.56% | 7,607,904 |
| Public float | 44.49% | 21,753,615 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.Director · 10% owner | 34.35% | 16,795,919 |
Aslan FredCEOPresident and CEO · Director | 3.20% | 1,562,198 |
Bush JenniferCOO, CLO, Secy, Compliance Off | 0.71% | 346,710 |
Horan ChristopherChief Tech Operations Officer | 0.61% | 300,452 |
Huston Thad AllenChief Financial Officer | 0.45% | 220,000 |
Banerjee SubhashisChief Medical Officer | 0.31% | 152,000 |
Raymon HeatherSVP, Research and Development | 0.31% | 151,323 |
Kolchinsky PeterDirector · 10% owner | — | — |
RA Capital Healthcare Fund LPDirector · 10% owner | — | — |
RA Capital Nexus Fund III, L.P.Director | — | — |
Institutional holders 36
View all →| Holder | Value | % of shares |
|---|---|---|
| $63.46M | 20.15% | |
| $10.10M | 4.81% | |
| $6.91M | 3.29% | |
| $6.74M | 1.42% | |
| $2.78M | 1.33% | |
| $2.23M | 1.06% | |
| $1.61M | 0.34% | |
| $1.28M | 0.61% | |
| $1.06M | 0.50% | |
| $832.7K | 0.40% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $75.00M | +6.5M +74.89% | 15,203,995 31.10% of shares | high |
| Jun 11, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $4.34M | +549K +3.50% | 16,231,717 33.20% of shares | high |
| Jun 12, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $3.35M | +391K +2.41% | 16,622,736 34.00% of shares | high |
| Jun 9, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $3.31M | +479K +3.15% | 15,683,034 32.08% of shares | high |
| Jun 16, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $1.11M | +125K +0.75% | 16,763,043 34.29% of shares | high |
| Jun 25, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $275.3K | +31K +0.18% | 16,794,043 34.35% of shares | medium |
| Jun 15, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $138.6K | +15K +0.09% | 16,638,150 34.03% of shares | medium |
| Feb 15, 2026 | Aslan Fred CEO | Other | Common Stock | $58.4K | -15K -0.93% | 1,562,198 3.20% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Viking Global Investors LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ARTV | — | 04317A107 |